There exists a long list of reasons not to take drugs: addiction, decreased productivity, deleterious health effects, damage to personal relationships, and the chance of fatal overdose are just a handful. To this tally of negative consequences, researchers have added another: an increased risk of suicide.
What explains such a rapid rise in price for a drug that has been off-patent for years?
A scathing report by the General Accountability Office, a federal watchdog organization, exposes serious flaws in the needed data collection by the FDA for fast-tracked drugs.
A review of government statistics by two Princeton economists reveals a disturbing, and surprising, rising trend of mortality rates among middle-aged white Americans. The likely causes: drugs, both legal and illicit, liver diseases, alcohol and suicide.
In a recent Wall St. Journal Op-Ed, former FDA associate commissioner Dr. Scott Gottlieb explains how the several-year-duration shortages of common generic drugs came about. That would be through excessive regulation, and not because of Big Pharma greed, which Hillary Clinton wants you to believe.
When a mild fever strikes healthy kids or adults, that small temperature rise is usually followed with a move towards the medicine cabinet. But there's a broad body of research that indicates that so-called over-the-counter remedies are simply unnecessary, because the body is perfectly designed to handle this physiological intrusion.
Disturbing reports about commonly used drugs mean...what? Screening tests over-used, dietary recommendations revamped. In summary: Science Marches On. That s what science is all about, as new data lead to new conclusions for those able to adjust.
Here s a simple question with nothing even close to a simple answer: Do cancer drugs cost too much? ACSH s Dr. Josh Bloom, who has written frequently on this subject, including an op-ed the New York Post thinks that al too often they are. He says, There are obvious cases of recently approved cancer drugs that offer very little benefit in terms of either disease-free progression or extension of life. The annual cost for these drugs is roughly $100,000, but
The answer is you won t believe it. ACSH s Dr. Josh Bloom s new Science 2.0 piece examines why GNC and other supplement retailers are allowed to sell a stimulant called BMPEA
On Wednesday, the U.S. Department of Health and Human Services (DHHS) proposed a plan to significantly increase the information reported on clinical trials related to drugs, devices, and other interventions. The proposed plan would apply to the National Institutes of Health (NIH) publicly accessible database, ClinicalTrials.gov.
Anaphylaxis (a severe, systemic allergic reaction) can be life-threatening. While this life-threatening reaction is quite uncommon, among the commonest causes of anaphylaxis include drug allergies, food allergies, and insect bites and stings. People who are known to be
While it s good to see that The New York Times is taking note of the crisis of antibiotic resistance, it is unfortunate that they could not be